Event JSON
{
"id": "bdbd3acc122d366e029c61ce5b46fad7171d9db0241e5b5cd84daad4148784d9",
"pubkey": "1c7eb0cd9f714c26329c9d3f257ab1ea4f2647f4609b3ad7d9a0a7406a9f4787",
"created_at": 1721340443,
"kind": 1,
"tags": [
[
"p",
"935cec1860181c99dd315cd00be8a18d6a679851b83fac6c09b3a0955bb1d591",
"wss://relay.mostr.pub"
],
[
"p",
"0b32dfc9f17bbcade06401bc0c73380682824773cd0c566a578042425604a33b",
"wss://relay.mostr.pub"
],
[
"e",
"1b0f75d4b61a6934e44520d0dea04e58d16d31b4a6db5337872a64d18aa56076",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://genomic.social/users/statesdj/statuses/112809767290393068",
"activitypub"
]
],
"content": "nostr:npub1jdwwcxrqrqwfnhf3tngqh69p344x0xz3hql6cmqfkwsf2ka36kgs2xawld the cost of GLP-1 drugs in Europe is an order of magnitude lower than it is in the US. At European prices, these drugs will be highly cost-effective and prevent substantial obesity related suffering and death",
"sig": "71afc0338f6fe177de6a428fa87965640ac8ab322e46c2c5341b8bfd0789bd78e0e648b131b7816bf21b62597a7137b1f0c714afb16f1ce52bb236ade09a3530"
}
